Tokyo, Jan. 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060449) titled 'Effects on Physical Condition from Using Plasma Irradiation Equipment' on Jan. 23.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -but assessor(s) are blinded Control - No treatment

Primary Sponsor: Institute - Japan Clinical Trial Association

Condition: Condition - Healthy adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Effects on Physical Condition from Using Plasma Irradiation Equipment Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - For 5 days, receive 30 minutes of plasma irradiation per day using Test Article A. Interventions/Control_2 - For 5 days, receive 30 minutes of plasma irradiation per day using Test Article B.

Eligibility: Age-lower limit - 40 years-old = Gender - Male and Female Key inclusion criteria - Subjects who frequently feel tired in daily life or experience a noticeable tendency to tire easily Subjects who feel they catch colds more easily or experience more frequent health setbacks Subjects who do not consider their sleep quality perfect or are dissatisfied with it Subjects who can maintain their daily routine prior to this trial throughout the trial period Subjects who can arrive on time and participate for 5 consecutive days Subjects able to drink the provided 1.0L of water daily Subjects meeting all of the above conditions Key exclusion criteria - Pregnant or breastfeeding individuals Subjects currently receiving treatment or prescriptions for chronic fatigue or chronic fatigue syndrome Subjects suffering from serious illnesses Subjects undergoing treatment under a physician's supervision (e.g., hormone replacement therapy, drug therapy, exercise therapy, dietary therapy) Subjects taking supplements, functional foods, or medications that affect the immune system Subjects who plan to take or are taking supplements, functional foods, or medications that affect immunity, sleep, body fat, or skin health during the trial period Subjects with food allergies Subjects with a history of drug dependence Subjects with alcohol dependence or who are heavy smokers Subjects who wish to receive or plan to receive vaccinations within 30 days prior to the trial start date or during the trial period Subjects working night shifts or rotating day-night shifts Subjects who have participated in another clinical trial within the past month or plan to participate during this trial period Other individuals deemed inappropriate by the responsible physician Target Size - 32

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2025 Year 12 Month 05 Day Date of IRB - 2025 Year 12 Month 11 Day Anticipated trial start date - 2026 Year 01 Month 19 Day Last follow-up date - 2026 Year 01 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069165

Disclaimer: Curated by HT Syndication.